Moberg Pharma announces partnership with Emerson Group

NEW YORK — Moberg Pharma on Tuesday announced that it has entered into an agreement with Emerson Healthcare — a division of Emerson Group — who will provide logistical services and all order to cash functions for retailer and wholesaler customers in the United States, according to the company. 

 

Along with the announced outsourcing agreement, the companies also are entering into a new sales representation agreement with Emerson Group. The agreements — which take effect Dec. 1 — will result in significant savings in sales and administrative costs for Moberg.

 

“We are pleased to expand the successful relationship with Emerson. Outsourcing these services will provide immediate savings in freight costs, as well as reducing focus of internal resources on non-value added activities. Under this new model our U.S. team will be able to spend more time and effort on activities that directly drive sales and build brand equity,” said Peter Wolpert, CEO of Moberg Pharma AB.

 

Scott Emerson, president and founder of Emerson Group, added: “We are excited about Moberg’s model to drive growth through a unique combination of innovation and brand equity. The expanded partnership unlocks additional value and enables us to support Moberg’s growth in the United States in an excellent way.”